Keith Speights: Now, speaking of GlaxoSmithKline, the company's CEO, Emma Walmsley, is revealing more details about the upcoming split of its pharmaceutical and consumer businesses today. There's an activist investor though, Elliott Management, that could push for more drastic actions.